Events

JUNE 18-19, 2013 - SHANGHAI, CHINA
The China Medical Affairs Summit is a brand new event for 2013 and the first event of its kind in China. The importance of medical affairs and its collaboration with commercial departments have increased greatly in the past few years and every multinational pharma has invested very heavily in this area. The conference aims to provide the first major global forum for medical affairs and marketing experts to gather and share ideas and best practices to help develop more standardized and effective medical strategies and brand medical planning. We are expecting 150-200 medical affairs and marketing executives at the inaugural meeting.

SEPTEMBER 17-18, 2013 - SUZHOU, CHINA
DeviceChina is the industry's top event that attracts high-end professionals interested in China's medical device industry. Over 250 of the most influential medical device inventors, entrepreneurs, executives, investors and government officials attend DeviceChina. The event highlights all aspects of the medical device area from investment, the latest R&D developments, regulatory topics and partnerships.

OCTOBER 21-23, 2013 - SHANGHAI, CHINA
At PharmAsia Summit, Elsevier and BayHelix will bring together a gathering of industry leaders to discuss the major strategic challenges facing the global pharmaceutical industry and potential solutions for renewed growth. We’ll provide the data, backed with case studies to demonstrate new ways of thinking globally. To learn more about PharmAsia Summit Shanghai, please visit us at www.pharmasiasummit.com.

NOVEMBER 13-15, 2013 - BEIJING, CHINA
The annual CHINATRIALS Summit has established itself as the must-attend industry-focused event for global clinical development executives in China. This year's event will feature over 100 speakers from leading pharmaceutical and biotech companies who will share their latest insights for successfully conducting clinical trials in China. You will meet hundreds of new contacts as you network with over 400 of your global clinical peers. CHINATRIALS draws the highest ratio of pharmaceutical/biotech attendees of any Asia-focused clinical development conference and is the only clinical event you need to attend this year to stay updated on China’s fast-moving clinical development industry.

MARCH 4-6, 2014 - SHANGHAI, CHINA
The China Healthcare Investment Conference is the premier event of its kind in China. As the leading event of the year focusing on rapidly-growing Chinese healthcare companies, the Conference will be a great opportunity to meet with emerging companies, industry leaders, key governmental officials and avid investors from China and the West. The conference brings together those company executives, entrepreneurs, investors, services providers and government officials interested in and committed to the development of the China healthcare industry.

MAY 29-30, 2013 - BEIJING, CHINA
ChinaBio^® Partnering Forum is the premier life science partnering event in China. Held on May 29–30, 2013 in Beijing, the event will attract biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies for two days of productive partnering.

The 2012 event brought together 719 attendees from over 432 companies and 23 countries for two days of intense partnering. Participants included most of the major pharma as well as many of China’s biopharmaceutical companies and CROs/CMOs. Join us to meet global pharmas, China biotech companies, VCs and others interested in funding or developing technologies in China.

To receive the discount, please be sure to enter 'CBLY20' in the Promo Code field while completing the registration form. After submitting the form, please contact Emily Zhang at +86 21 5137 0751 ext. 20 to complete your payment. Visit http://chinabiollc.com/events/CBPF2013/

OCTOBER 15-16, BEIJING, CHINA
Join the Food and Drug Law Institute (FDLI) for a two-day conference where government officials and internationally renowned experts will discuss pharmaceutical, medical device and food law, regulation and policy in China and the United States. The conference will focus on updates in regulations, business opportunities and policy challenges to producing safe products and promoting the public health.